Smart pills are miniature electronic devices that are shaped and designed in the mold of pharmaceutical capsules. These pills are used for sensing, imaging, and drug delivery.
The global ingestible smart pills market is estimated to account for US$ 1,175.4 Mn in terms of value and is expected to reach US$ 1,734.3 Mn by the end of 2027.
Global Ingestible Smart Pills Market: Drivers
Increasing adoption of smart pills is expected to propel growth of the global ingestible smart pills market over the forecast period. For instance, in January 2020, New University of Colorado adopted etectRx, Inc.’s ID-Cap System in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication.
Global Ingestible Smart Pills Market: Opportunities
Increasing geriatric population is expected to boost demand for digital medicine, thereby offering lucrative growth opportunities for players in the global ingestible smart pills market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Global Ingestible Smart Pills Market: Restraints
Limited coverage in terms of reimbursement is expected to hinder growth of the global ingestible smart pills market. Changes in reimbursement policies have played a crucial role in the past few years. Reimbursement for patient monitoring systems by government payer organizations and private payers is limited. As the purpose is monitoring, there is no positive outcome from the use of these devices as per the established and scalable outcomes of treatment devices. Therefore, reimbursement for patient monitoring pills used in diagnostic devices is not provided by health insurance companies.
Key Takeaways:
The global ingestible smart pills market was valued at US$ 1,111.8 Mn in 2019 and is forecast to reach a value of US$ 1,734.3 Mn by 2027 at a CAGR of 5.7% between 2020 and 2027. Major factor driving the growth of global ingestible smart pills market during the forecast period include increasing prevalence of gastrointestinal diseases, and several benefits of ingestible smart pills.